Filing Details
- Accession Number:
- 0001437749-20-019217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-02 16:03:26
- Reporting Period:
- 2020-08-27
- Accepted Time:
- 2020-09-02 16:03:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
922247 | Cyclo Therapeutics Inc. | CTDH | Industrial Organic Chemicals (2860) | 593029743 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1606624 | Novit, L.p. | 966 Hungerford Drive Rockville, MD 20850 | No | No | Yes | No | |
1648366 | Novit U.s., Inc. | 966 Hungerford Drive Rockville, MD 20850 | No | No | Yes | No | |
1648828 | Katarzyna Kusmierz | 966 Hungerford Drive Rockville, MD 20850 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-27 | 10,000,000 | $0.00 | 21,517,582 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2020-08-27 | 10,000,000 | $0.00 | 10,000,000 | $0.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000,000 | 2020-08-27 | 2027-08-27 | No | 4 | P | Direct |
Footnotes
- The reported securities consist of 10,000,000 "Units" purchased by the reporting person for $0.10 per Unit. Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock.
- Represents securities directly owned by Novit, L.P. ("Novit"). Each of the other Reporting Persons are indirect beneficial owners of such securities as follows: Novit U.S., Inc. is the general partner of Novit, and Katarzyna Kusmierz is the trustee of the NAP Trust and VN Trust, which indirectly own all of the outstanding partnership interests in Novit.